• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群偏好,比较抑郁症和心脏病的质量调整生命年的支付意愿。

Willingness to pay for a quality-adjusted life year for depressive disorders compared to heart disease based on population preferences.

机构信息

Department of Psychology, University of Hildesheim, Hildesheim, Germany.

Department of Clinical Psychology and Psychotherapy, University of Hildesheim, Universitätsplatz 1, 31141, Hildesheim, Germany.

出版信息

Qual Life Res. 2021 Jul;30(7):1985-1995. doi: 10.1007/s11136-021-02772-x. Epub 2021 Feb 15.

DOI:10.1007/s11136-021-02772-x
PMID:33590463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8233267/
Abstract

PURPOSE

According to estimations of the World Health Organization, depressive disorders, and cardiovascular disease will be the leading causes for global burden of disease in 2030. The aim of the present study was to estimate the value a representative sample of the German population places on quality-adjusted life years (QALYs) for depressive disorders compared to heart disease.

METHODS

A representative sample of N = 967 of the German general public was randomly presented with one of two hypothetical health-loss scenarios: One version of the questionnaire presented respondents with health loss due to depression, while the other version dealt with health loss due to experiencing a heart disease. Respondents were asked to indicate their willingness to pay (WTP) for four hypothetical health-gain scenarios with different treatment options.

RESULTS

In the depression questionnaire median WTP values ranged from 1000 to 1500 EUR; in the heart disease questionnaire from 1000 to 2000 EUR. Results of the Mann-Whitney U-Test and Median Test indicate higher WTP values for heart disease compared to depressive disorders when QALY gains were minor and stretched over a long period of time, and when treatment with bypass operation (rather than treatment with ECT) was offered. Zero WTP was significantly higher in all scenarios of the depression questionnaire in comparison to the hearth disease questionnaire.

CONCLUSION

Results indicate that respondents valued the necessity of paying for treatment higher when presented with heart disease compared to depression.

摘要

目的

根据世界卫生组织的估计,到 2030 年,抑郁障碍和心血管疾病将成为全球疾病负担的主要原因。本研究旨在评估德国有代表性的人群样本对抑郁障碍(与心脏病相比)调整后的生命质量(QALY)的重视程度。

方法

采用随机抽样的方法,对德国普通公众中的 967 名代表样本进行了问卷调查,其中一个版本的问卷呈现了因抑郁而导致的健康损失,而另一个版本则涉及因心脏病而导致的健康损失。受访者被要求对四个不同治疗方案的假设健康获益场景表明其支付意愿(WTP)。

结果

在抑郁问卷中,中位数 WTP 值范围在 1000 至 1500 欧元之间;在心脏病问卷中,中位数 WTP 值范围在 1000 至 2000 欧元之间。Mann-Whitney U 检验和中位数检验的结果表明,当 QALY 增益较小且持续时间较长,以及提供旁路手术(而不是 ECT 治疗)时,与抑郁障碍相比,受访者对心脏病的 WTP 值更高。在所有抑郁问卷的情景中,零 WTP 显著高于心脏病问卷。

结论

结果表明,与抑郁障碍相比,当呈现心脏病时,受访者对治疗的必要性支付意愿更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/378c/8233267/689375c793a2/11136_2021_2772_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/378c/8233267/0ac50d4bec2f/11136_2021_2772_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/378c/8233267/689375c793a2/11136_2021_2772_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/378c/8233267/0ac50d4bec2f/11136_2021_2772_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/378c/8233267/689375c793a2/11136_2021_2772_Fig2_HTML.jpg

相似文献

1
Willingness to pay for a quality-adjusted life year for depressive disorders compared to heart disease based on population preferences.基于人群偏好,比较抑郁症和心脏病的质量调整生命年的支付意愿。
Qual Life Res. 2021 Jul;30(7):1985-1995. doi: 10.1007/s11136-021-02772-x. Epub 2021 Feb 15.
2
Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study.患者与非患者受访者中抑郁症质量调整生命年(QALY)的货币估值:一项配对支付意愿研究。
Clin Psychol Eur. 2021 Dec 23;3(4):e3855. doi: 10.32872/cpe.3855. eCollection 2021 Dec.
3
Value of Electroconvulsive Therapy in the General Public: A Willingness to Pay Study in Germany.电抽搐疗法在普通大众中的价值:德国的支付意愿研究。
J ECT. 2021 Mar 1;37(1):51-57. doi: 10.1097/YCT.0000000000000721.
4
Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.对基础胰岛素相关属性改善的偏好:瑞典糖尿病和非糖尿病患者群体的时间权衡与支付意愿调查
J Med Econ. 2016 Oct;19(10):945-58. doi: 10.1080/13696998.2016.1187152. Epub 2016 May 31.
5
[The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].[德国抑郁症的负担——欧洲精神障碍流行病学研究(ESEMeD)的结果]
Psychiatr Prax. 2007 Sep;34(6):292-301. doi: 10.1055/s-2006-940066.
6
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.社区成员和患者对与带状疱疹相关的临时健康状态的偏好为基础的 QALY 的支付意愿。
Pharmacoeconomics. 2009;27(12):1005-16. doi: 10.2165/11314000-000000000-00000.
7
Willingness to pay for a quality-adjusted life-year: the individual perspective.对质量调整生命年的支付意愿:个体视角。
Value Health. 2010 Dec;13(8):1046-55. doi: 10.1111/j.1524-4733.2010.00781.x. Epub 2010 Sep 3.
8
A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?对获取每质量调整生命年支付意愿的研究进行的系统评价:这是否能证明成本效益阈值的合理性?
PLoS One. 2015 Apr 9;10(4):e0122760. doi: 10.1371/journal.pone.0122760. eCollection 2015.
9
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.支付意愿以获得额外一年质量调整生命年:来自中国的一项基于人群的调查。
Appl Health Econ Health Policy. 2022 Nov;20(6):893-904. doi: 10.1007/s40258-022-00750-z. Epub 2022 Aug 8.
10
Willingness to pay for QALY: perspectives and contexts in Japan.对 QALY 的支付意愿:日本的观点和背景。
J Med Econ. 2019 Oct;22(10):1041-1046. doi: 10.1080/13696998.2019.1639186. Epub 2019 Aug 6.

引用本文的文献

1
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity.每质量调整生命年的支付意愿:以年龄和疾病严重程度为重点的需求侧估值系统评价
Appl Health Econ Health Policy. 2025 Sep 17. doi: 10.1007/s40258-025-01005-3.
2
A systematic review on the direct approach to elicit the demand-side cost-effectiveness threshold: Implications for low- and middle-income countries.一项关于直接 elicitation 需求方成本效益阈值的系统评价:对低收入和中等收入国家的启示。
PLoS One. 2024 Feb 8;19(2):e0297450. doi: 10.1371/journal.pone.0297450. eCollection 2024.

本文引用的文献

1
Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.目前在德国精神病学领域中的电抽搐治疗和重复经颅磁刺激的临床实践。
Eur Arch Psychiatry Clin Neurosci. 2021 Feb;271(1):181-190. doi: 10.1007/s00406-020-01099-x. Epub 2020 Jan 29.
2
The association of depression stigma with barriers to seeking mental health care: a cross-sectional analysis.抑郁污名与寻求心理健康服务障碍的关联:一项横断面分析。
J Ment Health. 2020 Apr;29(2):182-190. doi: 10.1080/09638237.2019.1644494. Epub 2019 Aug 2.
3
Willingness to pay for QALY: perspectives and contexts in Japan.
对 QALY 的支付意愿:日本的观点和背景。
J Med Econ. 2019 Oct;22(10):1041-1046. doi: 10.1080/13696998.2019.1639186. Epub 2019 Aug 6.
4
When is it too expensive? Cost-effectiveness thresholds and health care decision-making.何时成本过高?成本效益阈值与医疗保健决策。
Eur J Health Econ. 2019 Mar;20(2):175-180. doi: 10.1007/s10198-018-1000-4.
5
[Rationality and freedom in medicine: the case of electroconvulsive therapy].[医学中的合理性与自由:以电休克治疗为例]
Nervenarzt. 2018 Nov;89(11):1248-1253. doi: 10.1007/s00115-018-0564-7.
6
Life satisfaction, QALYs, and the monetary value of health.生活满意度、质量调整生命年和健康的货币价值。
Soc Sci Med. 2018 Aug;211:131-136. doi: 10.1016/j.socscimed.2018.06.009. Epub 2018 Jun 18.
7
Estimating a constant WTP for a QALY-a mission impossible?估算一个 QALY 的恒定意愿支付值——一项不可能完成的任务?
Eur J Health Econ. 2018 Jul;19(6):871-880. doi: 10.1007/s10198-017-0929-z. Epub 2017 Sep 21.
8
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
9
Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.降低心血管疾病全球负担,第 1 部分:流行病学和危险因素。
Circ Res. 2017 Sep 1;121(6):677-694. doi: 10.1161/CIRCRESAHA.117.308903.
10
How you ask is what you get: Framing effects in willingness-to-pay for a QALY.提问方式决定所得结果:支付意愿中质量调整生命年的框架效应。
Soc Sci Med. 2016 Feb;150:40-8. doi: 10.1016/j.socscimed.2015.11.055. Epub 2015 Dec 2.